Mangoceuticals, Inc. (NASDAQ:MGRX) is a company focused on developing, marketing and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated drug branded “Mango,”.Mangoceuticals, Inc. MGRX Company’s Co-Founder and CEO, Jacob Cohen, along with the MangoRx family, including Company officials and members of the executive management team, rang the Nasdaq Closing Bell on Thursday, May 18, 2023. Since then, MGRX has been on a roll to promote its flagship product.
Today, Mangoceuticals, Inc. (NASDAQ:MGRX) announced that it has signed a sponsorship agreement with GaS Digital Network, a well-established digital comedy platform inclusive of 22 podcasts with original content in comedy, politics, music, sports, dating, and self-improvement and with a reach of approximately 5 million listeners per month (“GaS Digital” or “The network”).
GaS Digital will be responsible for promoting and incorporating Mango into each sponsored episode. Along with other promotional content, GaS Digital will work to generate 1 million unique impressions over the span of 2 months. This involves verbally communicating Mango through organic conversations and announcements as well as key product placements. As this deal is also a partnership, MangoRX and GaS Digital may elect to further the relationship with larger brand-focused projects.
Last week MGRX announced that it has been engaged as a new sponsor for Barstool Sports’ “Only Stans” podcast ( “We couldn’t be more excited to have the opportunity to sponsor the hugely popular Only Stans podcast,” stated MGRX Co-Founder and CEO, Jacob Cohen. “It isn’t easy to find, land, and execute a sponsorship this on-target from a branding perspective. This is a wildly popular podcast with a massive audience that resonates especially well with our target market. And we are thrilled to have access to that audience to help them truly appreciate our product benefits.”
MGRX is currently trading at $1.66. Considering the public offering was priced at $4 per share there could be a  huge upside potential for this NASDAQ listed pharmaceutical stock. Watch the video below to know more about MGRX.
Read More:
Watch the video below to get more info on MGRX–TjfGycZzk

In the world of stocks, Lumen Technologies Inc. (LUMN) experienced an upturn with the closing price of $2.26, marking a positive change of $0.13 or 6.10%. The market closed at 4:00 PM EDT, with an impressive volume of 34.26 million shares being traded, compared to the three-month average volume of 27.26 million shares. Currently, Lumen Technologies Inc. boasts a market capitalization of $2.27 billion.

Nikola Corporation (NKLA) also had a bullish day, closing at a rate of $1.08, indicating an increment of $0.17 or a whopping 18.16%. At the market closing time of 4:00 PM EDT, the trading volume stood at 119.20 million shares, substantially higher than the average volume of 33.90 million shares over the past three months. The market cap of Nikola Corporation currently stands at around $774.13 million.

Meanwhile, Faraday Future Intelligent Electric Inc. (FFIE) saw a modest increase, with its last price pegged at $0.349. This signifies a rise of $0.02 or 5.76%. Trading volume at closing time (4:00 PM EDT) was 63.80 million shares, which is a bit lower than the average volume of 75.50 million shares. The company has a market cap of $446.66 million.

Lastly, WeWork Inc. (WE) ended the trading day with a price of $0.21, up by $0.01, translating into a percentage increase of 7.25%. As the market wrapped up at 4:00 PM EDT, 33.47 million shares of WeWork had changed hands, compared to its three-month average volume of 16.69 million shares. The co-working space provider’s market cap sits at approximately $166.46 million.


Disclaimer: Please ensure to fully read and comprehend our disclaimer found at A payment of $4,500 was received by from Bullyzeye Media LLC for content distribution on MGRX, from 06/12/2023 to 07/07/2023. is neither an investment advisor nor a registered broker. No current owner, employee, or independent contractor of is registered as a securities broker-dealer, broker, investment advisor, or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. This article may contain forward-looking statements as defined under Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. These statements, often incorporating terms like “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or similar expressions about future performance or conduct, are based on present expectations, estimates, and projections, and are not historical facts. They carry various risks and uncertainties that may result in significant deviation from the anticipated results or events. Past performance does not guarantee future does not commit to updating forward-looking statements based on new information or future events. Readers are encouraged to review all public SEC filings made by the profiled companies at It is always important to conduct thorough due diligence and exercise caution in is not managed by a licensed broker, a dealer, or a registered investment adviser. The content here is purely informational and should not be taken as investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor regarding forward-looking statements. Any statement that projects, foresees, expects, anticipates, estimates, believes, or understands certain actions to possibly occur are not historical facts and may be forward-looking statements. These statements are based on expectations, estimates, and projections that could cause actual results to differ greatly from those anticipated.Investing in micro-cap and growth securities is speculative and entails a high degree of risk, potentially leading to a total or substantial loss of investment. Please note that no content published here constitutes a recommendation to buy or sell a security. It is solely informational, and you should not construe it as legal, tax, investment, financial, or other advice. No content in this article constitutes an offer or solicitation by or any third-party service provider to buy or sell securities or other financial instruments. The content in this article does not address the circumstances of any specific individual or entity and does not constitute professional and/or financial advice. is not a fiduciary by virtue of any person’s use of or access to this content. Source:

Leave a Reply

Your email address will not be published. Required fields are marked *